Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY

Mid Cap | Pharmaceuticals & Drugs

1273.90

-1.15 (-0.09%)

< Home < Back

Dr. Reddy’s Laboratories informs about press release

Date: 16-05-2026

Dr. Reddy’s Laboratories has informed that it enclosed a Press Release, ‘Dr. Reddy's Laboratories Launches its Generic Semaglutide Injection in Canada.’

The above information is a part of company’s filings submitted to BSE.